Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Merrimack Pharmaceuticals ($MACK) could keep surging and here’s why
Is the recent price action on Nuvalent Inc (NUVL) justified
Hempacco Co (HPCO) turns heads on Wall Street post revenue surge
Wall Street set for another red day as rates surge on…
Senti Biosciences Inc (NASDAQ:SNTI) surges post CEO’s participation on Gene Regulation…
Finance
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation…
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:HALO
Tag: NASDAQ:HALO
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces Findings From argnex’s third phase...
Gavins Felicity
-
March 30, 2022
0
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces That Janssen Biotech Has Received...
Gavins Felicity
-
December 16, 2021
0
Halozyme Therapeutics Inc. (NASDAQ:HALO) Reports Strong Q3 With Revenue Of $65.3...
Kate Hudson
-
November 17, 2020
0
Halozyme Therapeutics, Inc. (NASDAQ:HALO) And Argenx Expand Their Partnership And License...
Kate Hudson
-
October 23, 2020
0
Halozyme Therapeutics (NASDAQ:HALO) Announce Presentation of Phase 1b Study of Atezolizumab...
Kate Hudson
-
October 2, 2020
0
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Expects To Post Revenues Of $245 Million...
Kate Hudson
-
August 27, 2020
0
Halozyme Therapeutics Inc. (NASDAQ:HALO) Announce That The EMA Has Approved Jannsen’s...
Kate Hudson
-
June 16, 2020
0
Recent Post
Sales Force (NYSE:CRM) primed to bounce back (CRM,SAP,INTU,CDAY,DDOG,FICO)
Matt Wade
-
December 1, 2022
0
Salesforce Inc (NYSE:CRM) stock lost more than 8% today and last traded at $147. The stock was down a smidgen post-market. In...
Airlines stocks look bearish post Covid (UAL,JBLU,MESA,ALK,ALGT)
November 29, 2022
Grindr Inc (NYSE:GRND) technical setup looks bullish post merger
November 29, 2022
Recession-free stocks to place on top of radar (DG,TGT,DLTR,GOOG,BIG)
November 28, 2022
AMC Entertainment (AMC) looks poised for a Santa rally and here’s...
November 25, 2022
